Background: Controlled hypertensive patients are particularly vulnerable to peri-induction hemodynamic fluctuations, which may result in adverse cardiovascular and cerebrovascular events. This study compared the hemodynamic effects of etomidate and thiopentone sodium during induction of general anesthesia in controlled hypertensive patients undergoing elective surgery. Methods In this prospective randomized study, 60 controlled hypertensive patients aged 30–60 years undergoing elective surgery under general anesthesia were allocated into two groups. Group T received thiopentone sodium 5 mg/kg, while Group E received etomidate 0.3 mg/kg for induction. Heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, and oxygen saturation were recorded at baseline and at predetermined intervals following induction. Statistical analysis was performed using SPSS version 22.0, with p<0.05 considered significant. Results Baseline demographic and hemodynamic characteristics were comparable between the groups. Following induction, patients receiving etomidate demonstrated significantly better preservation of systolic blood pressure, diastolic blood pressure, and mean arterial pressure compared with those receiving thiopentone sodium. Sixty patients completed the study and were included in the final analysis. Significant differences were observed during the early post-induction period. Heart rate and oxygen saturation remained comparable between the groups throughout the study. Conclusion Etomidate provided superior hemodynamic stability compared with thiopentone sodium in controlled hypertensive patients undergoing elective surgery. Its ability to preserve arterial pressure during induction suggests that it may be a preferred induction agent when maintenance of cardiovascular stability is a primary perioperative objective.
Hypertension is a major public health concern and an important contributor to cardiovascular morbidity and mortality worldwide. A substantial proportion of patients presenting for elective surgery are hypertensive and require meticulous perioperative management. Owing to chronic cardiovascular adaptations, these patients may exhibit exaggerated hemodynamic responses to anesthetic interventions and are particularly vulnerable to complications resulting from sudden alterations in blood pressure and heart rate. [1,2]
Induction of general anesthesia is associated with significant cardiovascular changes. Laryngoscopy and tracheal intubation stimulate the sympathoadrenal system, resulting in transient increases in heart rate, arterial pressure, and myocardial oxygen demand. [3,4] Conversely, intravenous induction agents may produce
myocardial depression and vasodilation, leading to hypotension. In hypertensive patients, such fluctuations may increase the risk of myocardial ischemia, cerebrovascular events, and impaired organ perfusion.[5]
The choice of induction agent plays a crucial role in maintaining peri-induction hemodynamic stability. Thiopentone sodium has long been used for induction because of its rapid onset and cost-effectiveness; however, it may cause reductions in systemic vascular resistance and myocardial contractility, resulting in decreases in arterial pressure.[6] Etomidate, an imidazole-derived intravenous anesthetic, is characterized by minimal effects on myocardial function and vascular tone, making it a useful option in patients at risk of cardiovascular instability.[7]
Although previous studies have reported favorable hemodynamic profiles with etomidate compared with other induction agents, evidence focusing specifically on controlled hypertensive patients remains limited. [8–10] Since this subgroup is particularly susceptible to the adverse consequences of peri-induction hemodynamic disturbances, further evaluation of commonly used induction agents is warranted.
Therefore, the present study was undertaken to compare the hemodynamic effects of etomidate and thiopentone sodium in controlled hypertensive patients undergoing elective surgery under general anesthesia. The primary objective was to assess changes in systolic blood pressure, diastolic blood pressure, mean arterial pressure, and heart rate following induction, while secondary outcomes included oxygen saturation and peri-induction adverse effects.
Study Design and Setting
This prospective randomized comparative study was conducted in the Institute of Anaesthesiology and Critical Care, Madras Medical College and Rajiv Gandhi Government General Hospital, Chennai, India, between February 2022 and September 2022. The study was undertaken to compare the hemodynamic effects of etomidate and thiopentone sodium during induction of general anesthesia in controlled hypertensive patients undergoing elective surgical procedures.
Ethical Considerations
The study protocol was reviewed and approved by the Institutional Ethics Committee of Madras Medical College and Rajiv Gandhi Government General Hospital, Chennai (IEC Approval No.: EC Reg. No. DHR/EC/NEW/INST/2021/1618). Written informed consent was obtained from all participants before enrollment. The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki.
Study Population
A total of 60 patients with controlled essential hypertension scheduled for elective surgery under general anesthesia were enrolled in the study.
Inclusion Criteria
Exclusion Criteria
Sample Size and Randomization
Sample size was calculated based on a previous study comparing the hemodynamic consequences of induction with thiopentone sodium and etomidate in hypertensive patients. A minimum sample size of 29 patients per group was required to achieve adequate statistical power. To compensate for potential dropouts, 30 patients were included in each group, resulting in a total sample size of 60 patients.
Patients were randomly allocated into two equal groups using computer-generated random numbers. Group allocation was performed using sealed opaque envelopes opened immediately before induction of anesthesia. No participant was excluded after randomization, and all randomized patients were included in the final analysis.
Group T (n = 30): Received intravenous thiopentone sodium 5 mg/kg.
Group E (n = 30): Received intravenous etomidate 0.3 mg/kg.
Preoperative Assessment
All patients underwent a detailed pre-anesthetic evaluation, including medical history, physical examination, airway assessment, and routine laboratory investigations. Antihypertensive medications were continued until the day of surgery according to institutional protocol. Patients were kept fasting in accordance with standard preoperative fasting guidelines.
Anesthetic Technique
After arrival in the operating room, standard monitoring was instituted using continuous electrocardiography (ECG), non-invasive blood pressure (NIBP), and pulse oximetry. Baseline heart rate, systolic blood pressure, diastolic blood pressure, mean arterial pressure, and oxygen saturation were recorded.
All patients received intravenous glycopyrrolate 10 µg/kg, midazolam 0.03 mg/kg, and fentanyl 2 µg/kg as premedication. Following preoxygenation with 100% oxygen for three minutes, induction of anesthesia was performed according to group allocation.
Patients in Group T received intravenous thiopentone sodium 5 mg/kg, whereas patients in Group E received intravenous etomidate 0.3 mg/kg. Following loss of consciousness, neuromuscular blockade was achieved using intravenous vecuronium bromide 0.1 mg/kg. Laryngoscopy and endotracheal intubation were subsequently performed by an experienced anesthesiologist after adequate muscle relaxation.
Following successful intubation, anesthesia was maintained using oxygen, nitrous oxide, inhalational anesthetic agents, and intermittent doses of vecuronium according to institutional protocol.
Hemodynamic Measurements
Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), and peripheral oxygen saturation (SpO₂) were recorded at the following time points:
Mean arterial pressure was calculated using the formula:
MAP = DBP + (SBP − DBP)/3
Outcome Measures
The primary outcome measures were changes in systolic blood pressure, diastolic blood pressure, mean arterial pressure, and heart rate following induction of anesthesia.
Secondary outcome measures included oxygen saturation and the occurrence of peri-induction adverse events.
Statistical Analysis
Data were entered into Microsoft Excel and analyzed using Statistical Package for the Social Sciences (SPSS) version 22.0. Continuous variables were expressed as mean ± standard deviation (SD), while categorical variables were expressed as frequencies and percentages.
Comparisons between the two groups were performed using the independent Student's t-test for continuous variables and the Chi-square test for categorical variables. A p-value less than 0.05 was considered statistically significant.
A total of 60 controlled hypertensive patients scheduled for elective surgery under general anesthesia were enrolled in the study. All eligible patients completed the study protocol and were included in the final analysis.
Figure 1. CONSORT Flow Diagram showing participant enrollment, randomization, allocation to intervention groups, follow-up, and analysis. Sixty controlled hypertensive patients were enrolled and randomized equally to receive thiopentone sodium (Group T) or etomidate (Group E). All participants completed the study and were included in the final analysis.
Baseline Characteristics
The baseline demographic and clinical characteristics of the study participants are summarized in Table 1. The mean age of patients in Group T was 43.03 ± 13.56 years, while that of Group E was 44.20 ± 12.60 years. There was no statistically significant difference in age distribution between the groups (p=0.730). Similarly, gender distribution and ASA physical status were comparable between the two groups.
|
Variable |
Group T (n=30) |
Group E (n=30) |
P value |
|
Age (years) |
43.03 ± 13.56 |
44.20 ± 12.60 |
0.730 |
|
Gender (Male/Female) |
12/18 |
13/17 |
0.79 |
|
ASA I |
5 |
8 |
0.532 |
|
ASA II |
25 |
22 |
0.430 |
Table 1: Comparison of demographic characteristics and ASA physical status between patients receiving thiopentone sodium (Group T) and etomidate (Group E). No statistically significant differences were observed, indicating comparable baseline characteristics.
Systolic Blood Pressure
The comparison of systolic blood pressure (SBP) between the study groups is shown in Table 2. Baseline SBP values were comparable between Group T and Group E (p=0.09). Following induction, a greater reduction in systolic blood pressure was observed in patients receiving thiopentone sodium. Statistically significant differences were noted at 1 minute (p=0.005), 3 minutes (p=0.003), 4 minutes (p=0.003), and 5 minutes (p=0.022) following induction.
|
Time |
Group T Mean ± SD |
Group E Mean ± SD |
P value |
|
Pre-induction |
125.97 ± 8.36 |
130.73 ± 13.02 |
0.09 |
|
1 min |
116.83 ± 10.53 |
125.80 ± 13.31 |
0.005 |
|
3 min |
112.60 ± 11.12 |
120.90 ± 9.35 |
0.003 |
|
4 min |
111.53 ± 10.53 |
120.13 ± 10.67 |
0.003 |
|
5 min |
111.40 ± 10.24 |
117.80 ± 10.88 |
0.022 |
Table 2. Comparison of Systolic Blood Pressure Following Induction. Mean systolic blood pressure (mmHg) recorded at various time intervals following induction of anesthesia. Patients receiving etomidate demonstrated significantly better preservation of systolic blood pressure during the post-induction period.
Diastolic Blood Pressure
Table 3 presents the comparison of diastolic blood pressure (DBP) between the two groups. Baseline DBP values were comparable (p=0.28). Following induction, patients in the thiopentone group experienced a significantly greater reduction in diastolic blood pressure than those in the etomidate group. Statistically significant differences were observed at 1 minute (p=0.01), 3 minutes (p=0.02), and 4 minutes (p=0.009). By 5 minutes after induction, the difference between groups was no longer statistically significant (p=0.32).
|
Time |
Group T Mean ± SD |
Group E Mean ± SD |
P value |
|
Pre-induction |
81.50 ± 5.32 |
83.70 ± 9.76 |
0.28 |
|
1 min |
74.30 ± 7.34 |
79.30 ± 8.53 |
0.01 |
|
3 min |
73.37 ± 9.29 |
78.57 ± 8.41 |
0.02 |
|
4 min |
72.60 ± 8.71 |
78.57 ± 8.41 |
0.009 |
|
5 min |
73.00 ± 7.95 |
74.93 ± 7.17 |
0.32 |
Table 3. Comparison of Diastolic Blood Pressure Following Induction. Mean diastolic blood pressure (mmHg) measured at different study intervals. Etomidate was associated with superior maintenance of diastolic blood pressure during the immediate post-induction period.
Mean Arterial Pressure
The comparison of mean arterial pressure (MAP) is shown in Table 4. Baseline MAP values were similar between the two groups (p=0.16). Following induction, patients receiving thiopentone sodium demonstrated a greater decline in MAP compared with those receiving etomidate. Significant differences were observed at 1 minute (p=0.004), 3 minutes (p=0.003), and 4 minutes (p=0.01), suggesting better hemodynamic stability with etomidate. Although MAP remained lower in the thiopentone group at 5 minutes, the difference was not statistically significant (p=0.10).
|
Time |
Group T Mean ± SD |
Group E Mean ± SD |
P value |
|
Pre-induction |
96.32 ± 5.70 |
99.38 ± 10.35 |
0.16 |
|
1 min |
88.48 ± 7.56 |
94.80 ± 9.09 |
0.004 |
|
3 min |
85.93 ± 8.88 |
92.68 ± 8.22 |
0.003 |
|
4 min |
86.51 ± 8.02 |
91.51 ± 8.04 |
0.01 |
|
5 min |
85.80 ± 8.08 |
89.22 ± 7.80 |
0.10 |
Table 4. Comparison of Mean Arterial Pressure Following Induction. Mean arterial pressure (mmHg) measured before and after induction of anesthesia. Etomidate demonstrated superior preservation of mean arterial pressure compared with thiopentone sodium.
The trend of mean arterial pressure over time is illustrated in Figure 2. Patients induced with etomidate maintained higher mean arterial pressure values throughout the study period compared with those receiving thiopentone sodium.
Heart Rate
Heart rate measurements at different study intervals are summarized in Table 5. Baseline heart rates were comparable between the groups (p=0.69). No statistically significant differences in heart rate were observed at any measured time point following induction (p>0.05).
|
Time |
Group T Mean ± SD |
Group E Mean ± SD |
P value |
|
Pre-induction |
89.97 ± 10.50 |
90.90 ± 7.81 |
0.69 |
|
1 min |
89.60 ± 10.25 |
88.87 ± 8.44 |
0.76 |
|
3 min |
88.97 ± 11.25 |
88.23 ± 8.13 |
0.77 |
|
4 min |
89.67 ± 11.16 |
86.50 ± 8.27 |
0.21 |
|
5 min |
89.70 ± 11.31 |
85.40 ± 8.62 |
0.11 |
Table 5. Comparison of Heart Rate Following Induction. Mean heart rate (beats per minute) recorded before and after induction of anesthesia. No significant differences were observed between the two groups throughout the study period.
Oxygen Saturation
The comparison of peripheral oxygen saturation (SpO₂) between the groups is presented in Table 6. Oxygen saturation remained within normal physiological limits throughout the study period in both groups. No statistically significant differences were observed between the two groups at any time point (p>0.05).
|
Time |
Group T Mean ± SD |
Group E Mean ± SD |
P value |
|
Pre-induction |
99.80 ± 0.48 |
99.87 ± 0.35 |
0.52 |
|
1 min |
99.87 ± 0.43 |
99.83 ± 0.37 |
0.70 |
|
3 min |
99.93 ± 0.25 |
99.87 ± 0.34 |
0.43 |
|
4 min |
99.90 ± 0.40 |
99.86 ± 0.43 |
0.71 |
|
5 min |
99.80 ± 0.66 |
99.86 ± 0.43 |
0.67 |
Table 6. Comparison of Peripheral Oxygen Saturation Following Induction. Mean peripheral oxygen saturation (%) recorded during the study period. Oxygen saturation remained stable and comparable in both groups throughout the observation period.
The present prospective randomized study compared the hemodynamic effects of etomidate and thiopentone sodium in controlled hypertensive patients undergoing elective surgery under general anesthesia. The findings demonstrated that etomidate provided superior hemodynamic stability during the immediate post-induction period, with better preservation of systolic blood pressure, diastolic blood pressure, and mean arterial pressure. Heart rate and oxygen saturation remained comparable between the two groups.
Maintenance of cardiovascular stability during induction is particularly important in hypertensive patients because chronic hypertension is associated with vascular remodeling, impaired baroreceptor sensitivity, and altered autoregulatory mechanisms.[11] Consequently, these patients are more vulnerable to adverse effects resulting from sudden fluctuations in blood pressure, including myocardial ischemia, cerebrovascular events, and impaired end-organ perfusion.[12]
In the present study, systolic blood pressure decreased following induction in both groups; however, the reduction was significantly greater in patients receiving thiopentone sodium. In contrast, systolic blood pressure remained closer to baseline values in the etomidate group throughout the observation period. These findings are consistent with those reported by Vijayalakshmi et al. and Shah et al., who demonstrated superior cardiovascular stability with etomidate compared with other induction agents. [13,14]
A similar trend was observed for diastolic blood pressure. Patients induced with thiopentone experienced a greater decline in diastolic pressure during the early post-induction period, whereas etomidate provided better preservation of vascular tone. These findings agree with previous studies by Karki et al. and Yagan et al., which also reported improved maintenance of diastolic blood pressure following etomidate induction. [15,16] Preservation of diastolic pressure is clinically important because coronary perfusion occurs predominantly during diastole, particularly in patients with cardiovascular disease.[17]
Mean arterial pressure is widely regarded as an important indicator of tissue perfusion and overall hemodynamic stability. In the present study, mean arterial pressure remained significantly higher in the etomidate group during the first few minutes following induction, suggesting better maintenance of systemic perfusion. Similar observations have been reported by Dalvi et al. and Hosseinzadeh et al., who demonstrated superior preservation of mean arterial pressure with etomidate-based induction techniques. [18,19]
Despite significant differences in blood pressure variables, heart rate remained comparable between the two groups throughout the study period. Similar findings have been reported in earlier comparative studies evaluating etomidate and thiopentone. [14,18] This suggests that the hemodynamic advantage of etomidate is primarily related to maintenance of arterial pressure rather than chronotropic effects.
The observed differences can be explained by the pharmacological properties of the study drugs. Thiopentone sodium produces dose-dependent myocardial depression and peripheral vasodilation, resulting in reductions in systemic vascular resistance and arterial pressure.[20] In contrast, etomidate exerts minimal effects on myocardial contractility, sympathetic nervous system activity, and vascular tone, thereby maintaining cardiovascular parameters closer to baseline values.[21] These characteristics make etomidate particularly useful in patients at risk of hemodynamic instability.
The findings of this study have important clinical implications. Controlled hypertensive patients constitute a significant proportion of the surgical population, and avoidance of peri-induction hypotension is often a major anesthetic objective. The superior preservation of systolic, diastolic, and mean arterial pressures observed with etomidate suggests that it may be a preferred induction agent when cardiovascular stability is a priority. Although transient adrenal suppression remains a concern, evidence indicates that a single induction dose is unlikely to result in clinically significant adverse outcomes in elective surgical patients.[18]
The strengths of this study include its prospective randomized design, standardized anesthetic protocol, and focus on a clinically relevant high-risk subgroup. However, certain limitations should be acknowledged. The study was conducted at a single center with a relatively small sample size, and hemodynamic assessment was limited to the immediate post-induction period. In addition, postoperative outcomes and biochemical markers of adrenal suppression were not evaluated. Larger multicenter studies are required to further validate these findings.
In conclusion, etomidate provided greater hemodynamic stability than thiopentone sodium during induction of anesthesia in controlled hypertensive patients. Its ability to preserve arterial pressure more effectively supports its use when maintenance of cardiovascular stability is a primary perioperative goal.
Etomidate provided superior hemodynamic stability compared with thiopentone sodium during induction of general anesthesia in controlled hypertensive patients undergoing elective surgery. Better preservation of systolic blood pressure, diastolic blood pressure, and mean arterial pressure was observed with etomidate, while heart rate and oxygen saturation remained comparable between groups. Given the increased vulnerability of hypertensive patients to peri-induction cardiovascular fluctuations, etomidate may be considered a preferred induction agent when maintenance of cardiovascular stability is a primary anesthetic objective. Further multicenter studies are needed to confirm these findings and assess long-term clinical outcomes.